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Abstract
Rare variants have been proposed to play a significant role in the onset and development of common diseases.
However, traditional analysis methods have difficulties in detecting association signals for rare causal variants
because of a lack of statistical power. We propose a two-stage, gene-based method for association mapping of
rare variants by applying four different noncollapsing algorithms. Using the Genome Analysis Workshop18 whole
genome sequencing data set of simulated blood pressure phenotypes, we studied and contrasted the falsepositive rate of each algorithm using receiver operating characteristic curves. The statistical power of these
methods was also evaluated and compared through the analysis of 200 simulated replications in a smaller
genotype data set. We showed that the Fisher’s method was superior to the other 3 noncollapsing methods, but
was no better than the standard method implemented with famSKAT. Further investigation is needed to explore
the potential statistical properties of these approaches.
Background
During the past five years, genome-wide association studies (GWAS) have rapidly become a standard method for
discovering susceptible genes for a variety of complex
diseases [1]. Up to now, hundreds of loci with more than
3000 single-nucleotide polymorphisms from approximately 7000 GWAS have been reported to be associated
with complex diseases [2]. Nevertheless, a large proportion of heritability is left unexplainable from GWAS
results that are mainly based on association signals captured by common variants [3]. One potential explanation
for this “missing heritability enigma” has been the contribution of rare variants, which is often not assessed in regular GWAS studies [3]. Unfortunately, traditional
methods often fail in association mapping of rare variants
because of poor statistical power. Several methods have
been proposed to detect association signals for rare variants with improvements in statistical power compared to
traditional methods [4-6].
* Correspondence: john@zork.wustl.edu
Department of Psychiatry, Washington University, 660 S. Euclid Ave., St.
Louis, MO 63110, USA

As part of Genetic Analysis Workshop 18 (GAW18),
simulated phenotypic data, based on a real sequencing
data set, were provided to the scientific community to
evaluate and compare statistical genetic methods for rare
variants association mapping. We consider a two-stage,
gene-based method to detect association signals for both
common and rare variants. We first obtain significance
p values by fitting a mixed effects model for each variant,
and then apply 4 noncollapsing algorithms to obtain the
gene-wise association p values. Collapsing (or burden)
methods combine variant information by assuming consistent direction of effects across variants. None of the
methods considered here adopt this assumption,
although some (Fisher’s, Gene Set Enrichment Analysis
[GSEA], sequence kernel association test [SKAT]) do
combine variant information.

Methods
Model fitting and algorithms

A mixed linear model was fitted for each variant as
described in previous literature [7]. The model was
defined as:Y = Xβ + Qv + Zμ + 
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where Y is the quantitative trait of interest (we used
first-visit systolic blood pressure [SBP] data were used
in this study); × is the genotype; b is the fixed effects of
the genotypes; and Q represents the population structure variables. In this study, we chose the first 10 principal components from principal component analysis
(PCA) for Q;ν is the fixed effects of Q; Z is the variable
that evaluates familial relatedness (the theoretical kinship matrix was used for Z); and µ is the random effects
coefficient for Z that corrects the polygenic impact.
After obtaining the variant-wise p values by fitting the
mixed linear model, four noncollapsing algorithms were
modified and applied to the data set to obtain the genewise association p values. The algorithms of the 4 methods are summarized as followed:
1. Naïve method. The most significant variant-wise p
values within a specific gene were chosen as the genewise association p values.
2. Fisher’s method [8]. The gene-wise statistics were
calculated through the following equation:
X = −2

k

i=1

where pi is the p value for variant i, and k is the total
number of variants within a specific gene. Because many
variants are highly correlated, the basic assumption of
independent tests for Fisher’s method is violated. Fisher’s
formula will not have a chi-square distribution, so we
assessed the significance via permutation analysis.
3. Simes’ method [9]. The gene-wise p value was summarized by the following equation:
 
kpi
Psimes = min
i
i
where pi is the p value for variant i, and k is the total
number of variants within a specific gene.
4. GSEA method [10,11]. The test statistics (indicated
as ES score) were aggregated from variant-wise p values
within each gene via a Kolmogorov-Smirnov-like process in which running sums are accumulated. The equation is given as:
⎧
⎫
⎨  |r |p
⎬

2
(j∗)
ES(S) = max
−
1≤j≤N ⎩
NR
N − NH ⎭
Gj∗∈S,j∗≤j
/

where N is the total number of variants, r(j) is the jth
largest statistic values, N H is the variant number of a
given gene, S is any given gene, P is the parameter that
gives a higher weight to variants with extreme statistic
value, arbitrarily set to 1 in this study, and NR is given by:

NR =
|r(j∗) |p
Gj∗eS

Statistical significance and adjustment for multiple
hypothesis testing were assessed by a 1000-permutationbased procedure. A family-wise error rate (FWER) procedure was used to adjust for multiple hypothesis testing.
The FWER is a highly conservative correction procedure
that seeks to ensure that the list of reported results does
not include even a single false-positive gene. In this
study, the FWER p value was calculated as the fraction of
all permutations whose highest statistics (or smallest
p values) in all genes is higher than a given gene. In addition to the 4 noncollapsing algorithms introduced above,
we also included 2 standard rare variants analysis methods: SKAT [12] and famSKAT [13] in our analysis. FamSKAT is an extended version of SKAT and can analyze
rare variant when family correlations are present.
Furthermore, to evaluate the statistical power of these
methods, we extracted the variant information related to
the 22 true-positive genes located on chromosome 3 and
analyzed these data for all 200 simulated phenotype
replicates.
Data and computation

loge (pi )

GjeS,j∗≤j
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The chromosome 3 sequencing data were analyzed only
for phenotype replicate number 1 because of a huge
computational burden. The sequencing data were annotated by ANNOVAR[14]. Intergenic variants (variants at
least 1 kilobase [kb] away from any known gene regions)
were excluded. We kept only variants mapped to regulatory regions.
To preserve the familial structure, a permutation-ofresiduals procedure was applied for the 1000 permutations [15,16]. First, we fitted a mixed effects linear model
on the phenotypic data with all predictors in the model
(except for genotype term) and preserve the residuals for
these models. Second, we shuffled the residuals (rather
than the phenotypic data used in an ordinary permutation procedure) and randomly assigned them to each
subject and generated 1000 phenotypic data replicates.
And third, we obtained the permuted statistics and
p values by fitting a univariate linear model with genotype as the only predictor of the residuals. This method
may introduce potential bias to the permuted statistics
and p values comparing to directly fitting the full model.
To quantify this potential bias, we randomly chose 1429
variants and calculated the percentage difference of the
−log10 scaled p values obtained from directly fitting a
full model and from the 2-step permutation procedure
proposed in this paper.
Genotypes were coded as dominant, that is, the genotypes with 1 or 2 minor alleles were coded as 1, while
genotypes with 2 major alleles were assigned 0. Variants
with minor allele frequency >0.3 in genome-wide association data set were selected for PCA. We used Eigenstrat 3.0 for this analysis [17]. The R package kinship2
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(http://cran.r-project.org/web/packages/kinship2/index.
html) was used to calculate the kinship coefficient
matrix for our data set. The R package coxme (http://
cran.r-project.org/web/packages/coxme/index.html) was
implemented for fitting the mixed linear model. The R
package SKAT (http://cran.r-project.org/web/packages/
SKAT/index.html) was implemented for rare variant
analysis with SKAT. The R source code for famSKAT
was downloaded (http://www.bumc.bu.edu/linga/
research/publications/famskat/) and implemented for
rare variant analysis. Receiver operating characteristic
(ROC) curves were made and compared among the 4
algorithms and two standard methods.

Results
The data consisted of 1237 genes with 87,190 variants
that passed the annotation criteria were extracted from
the sequencing data set of chromosome 3 for 849 subjects. After fitting the mixed linear model, the Q-Q plot
and histogram of p values of these 87,190 variants is
shown in Figure 1. To compare the 4 noncollapsing
methods and the 2 standard methods, ROC curves
based on these 6 methods were calculated and are
shown in Figure 2.
Data for the 22 true-positive genes with 1098 variants
were extracted and used for analysis with 200 simulated
phenotype replicates. The statistical power information
for the 6 methods was summarized and is presented in
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Table 1. The results of the permutation bias analysis
showed that the percentage difference was only approximately 10%, and the correlation coefficient of variantwise statistics was 0.9959. These results indicate that the
effects of this bias will be limited.

Discussion
The noncollapsing methods introduced in this paper have
been broadly used in testing the significance of biological
pathways in GWAS data sets [11]. When we substitute the
term"pathway” in these noncollapsing algorithms for the
term “gene” in sequencing analysis and “gene” for “variants,” we can apply these noncollapsing algorithms to
gene-based association detection through modifications.
An obvious advantage of aggregating p values (or statistics) by applying noncollapsing algorithms, compared to
ordinary variants collapsing methods, is that it is a method
free of the assumption that all the causal variants from a
gene have effects in the same direction. This assumption
may not be held in many scenarios even though it is the
assumed in many existing rare variants association mapping procedures.
Another advantage of this research is the utilization of
residuals-of-permutation procedure [15,16]. Conducting
a permutation on family data has been a challenge in statistical genetics research. Ordinary permutation procedures have been mostly utilized in case-control data,
which simply shuffle the phenotypic data and randomly

Figure 1 Q-Q plot and histogram for the mixed effects model. Q-Q plot (left) of −log10 scaled p values and histogram (right) for the mixed
effects model based on 1237 genes (87,190 variants) from 849 subjects. In Q-Q plot, black line, expected; blue dots, observed.
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Figure 2 ROC curves for 4 noncollapsing algorithms and 2 standard methods. ROC curves for 4 different pathway algorithms based on
1237 genes from 849 subjects on trait SBP (first visit). In the left plot, false-positive rate (FPR) ranges from 0 to 1. In the right plot, FPR is scaled
to be less than 0.1 as only the true-positive rate (TPR) with a low FPR is of interest. Black curve, naïve method; blue curve, Fisher’s method; red
curve, Simes’ method; green curve, GSEA method; purple curve, SKAT; yellow curve, famSKAT.

Table 1 Comparison of the power of the 4 noncollapsing and 2 standard methods
Chromosome

Gene

Power of methods
Naïve method

Fisher’s method

Simes’ method

GSEA method

SKAT

FamSKAT

3

ABTB1

0.015

0.18

0.025

0

0.075

0.01

3

ARHGEF3

0

0

0

0.035

0.005

0.005

0.015

0

0.015

0.035

0.01

0.015

0

0

0

0.015

0

0

0
0.005

0
0.005

0.085
0.005

0
0.04

0
0.01
0

3

B4GALT4

3

BTD

3
3

CXCR6
DNASE1L3

0
0.005

3

FBLN2

0.005

0

0

0.035

0

3

FLNB

0.01

0.015

0

0.03

0

0

3

LOC152217

0.09

0.145

0.135

0

0.275

0.04

3

MAP4

1

1

1

1

1

1

3

NMNAT3

0.005

0.04

0.005

0

0

0

3

PAK2

0.07

0

0.05

0

0

0

3
3

PDCD6IP
PPP2R3A

0.005
0.045

0
0.01

0.005
0.02

0.005
0

0.04
0.005

0.03
0.005

3

PTPLB

0

0

0

0.02

0.005

0

3

SCAP

0.025

0.005

0.04

0

0.045

0.065

3

SEMA3F

0

0

0

0

0

0

3

SENP5

0

0.02

0.01

0.045

0.01

0.005

3

SUMF1

0.085

0.005

0.06

0.01

0.015

0.005

3

TFDP2

0

0

0

0.035

0

0

3
3

TUSC2
ZBTB38

0.005
0.01

0
0.005

0.055
0.01

0
0.02

0.02
0.04

0
0

Power is calculated based on the analysis of the 200 simulated phenotypic replicates. The largest power for each gene is highlighted in bold.
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assigns them to each subject, thus cannot be directly
applied to family data because it destroys the family
structure. In this paper, instead of shuffling the phenotypic data, we shuffled the residuals obtained from fitting a
linear mixed effects model without genotype. These residuals have already accounted familial relatedness in the
model fitting step and therefore our permutation procedure preserves the familial structure.
From the ROC curves in Figure 2 we note that, overall,
the Simes’ method performed a little better than the other
5 methods, and that GSEA, SKAT, and famSKAT did not
perform as well. The other 2 methods were slightly better
than the GSEA, SKAT, and famSKAT methods. However,
when we limit the false-positive rate to be smaller than
0.1, as shown in the right hand plot of Figure 2 (in practice, only a high true-positive rate with a low false-positive
rate is of interest), we see that Fisher’s method and famSKAT performed better than the other methods at the low
false-positive rate range. They both capture approximately
15% of the causal genes (true positives) at a cost of only
5% false-positive signals. However, we did not test the significance of the ROC curves, so that all these observed differences could just be noise.
From the power analysis results in Table 1, we see that
the gene MAP4 was successfully identified to be significant for all simulated 200 replicates. All six methods
achieved 100% power for this gene. This result is reasonable because, according to the “answer sheet”, MAP4 has
the most “causal variants” and these variants have a relatively larger effect size comparing to the variants within
other genes. However, this result was obtained when we
only analyzed 22 genes. For a genome-scale analysis, the
significant signals may be missed as a consequence of
correction for multiple comparisons. We have analyzed
the whole genotypic data set of chromosome 3 with
simulated phenotypic replicate number 1 (1237 genes
and 87,190 variants). The result indicated that only naïve
method and the 2 standard methods identified gene
MAP4 to be significant. For the other 21 genes, the largest power was 0.275, which was achieved by SKAT for
LOC152217.
Several previous researchers have already applied the
noncollapsing methods proposed in this paper to conduct gene-based analysis [18,19]. However, this previous
work has mainly focused on common variants in GWAS
data set. As an attempt to apply these noncollapsing
algorithms to gene-based association tests using sequencing data, we have demonstrated some potentially promising aspects of this approach. However, several
problems remain unaddressed. One important issue is
the computational intensity. In this study, we have utilized a multiprocessor computing server with a 23 × 2.8
GHz CPU and 64GB of memory. The most time-consuming part of our analysis is the permutation-of-
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residuals process and linear model fitting of the permuted data sets. We have paralleled this process into 20
jobs, but it still takes around 30 hours to complete (this
is only the work done for 1 chromosome).
Compared to the permutation process, the p value
combination step can be completed much faster (~30
minutes). Because a lot of the non collapsing algorithms
require permutation procedures to create null distribution of the statistics, it is somewhat difficult to implement
them on a genome-wide-scale data set. In addition, many
noncollapsing algorithms cannot be utilized for a genebased association test directly without proper modifications. The choice of parameters in noncollapsing algorithm for rare variant association detection is more an art
than a science. Finally, adjustment for multiple hypothesis testing is another important issue that needs to be
addressed.
Our results indicate that the FWER method is too
conservative. For the future work, hierarchical modeling
combined with the Markov chain Monte Carlo method
may provide better solution to the multiple hypothesis
testing problems [20].

Conclusions
Our findings suggest that all the four new methods we
proposed along with the standard method implemented
with famSKAT were poor in statistical power. In sum,
more research is still needed in the statistical method of
association mapping for rare variants in the future.
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